DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
PYRANTEL
4
Small molecule
Approved
Unknown
Unknown
Helminthiasis
Unknown
PYRANTEL
×
Maximum Phase:
4
First Approval:
None
UNII:
4QIH0N49E7
Molecule Type:
Small molecule
Molecular Formula:
C11H14N2S
Molecular Weight:
206.31
AlogP:
2.5
PSA:
15.6
HBD:
0.0
HBA:
#RotB:
2.0
Source:
MAGNESIUM ACETATE TETRAHYDRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MAGNESIUM ACETATE TETRAHYDRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
I01G0EJC3B
Molecule Type:
Small molecule
Molecular Formula:
C4H14MgO8
Molecular Weight:
214.45
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DIACETYLMORPHINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Substance-Related Disorders
Unknown
DIACETYLMORPHINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
8H672SHT8E
Molecule Type:
Small molecule
Molecular Formula:
C21H24ClNO5
Molecular Weight:
405.88
AlogP:
1.99
PSA:
65.07
HBD:
0.0
HBA:
#RotB:
2.0
Source:
URAPIDIL
4
Small molecule
Approved
Unknown
Unknown
Hypertension; Pre-Eclampsia; Stroke
Unknown
URAPIDIL
×
Maximum Phase:
4
First Approval:
None
UNII:
A78GF17HJS
Molecule Type:
Small molecule
Molecular Formula:
C20H29N5O3
Molecular Weight:
387.48
AlogP:
0.72
PSA:
71.74
HBD:
1.0
HBA:
#RotB:
7.0
Source:
SULFAMETHOXYPYRIDAZINE
4
Small molecule
Approved
Unknown
Unknown
Bacterial Infections
Bacterial dihydropteroate synthase inhibitor
SULFAMETHOXYPYRIDAZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
T034E4NS2Z
Molecule Type:
Small molecule
Molecular Formula:
C11H12N4O3S
Molecular Weight:
280.31
AlogP:
0.87
PSA:
107.2
HBD:
2.0
HBA:
#RotB:
4.0
Source:
CLAMOXYL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CLAMOXYL
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PRAJMALIUM BITARTRATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PRAJMALIUM BITARTRATE
×
Maximum Phase:
4
First Approval:
None
UNII:
H671L9190Z
Molecule Type:
Small molecule
Molecular Formula:
C27H38N2O8
Molecular Weight:
518.61
AlogP:
2.48
PSA:
43.7
HBD:
2.0
HBA:
#RotB:
3.0
Source:
MUZOLIMINE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
MUZOLIMINE
×
Maximum Phase:
4
First Approval:
None
UNII:
07Z36289ZX
Molecule Type:
Small molecule
Molecular Formula:
C11H11Cl2N3O
Molecular Weight:
272.13
AlogP:
2.56
PSA:
58.69
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CARBENOXOLONE SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
CARBENOXOLONE SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
F1MP7242Z5
Molecule Type:
Small molecule
Molecular Formula:
C34H48Na2O7
Molecular Weight:
614.73
AlogP:
6.83
PSA:
117.97
HBD:
2.0
HBA:
#RotB:
5.0
Source:
BARBITAL SODIUM
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BARBITAL SODIUM
×
Maximum Phase:
4
First Approval:
None
UNII:
275L5M93QS
Molecule Type:
Small molecule
Molecular Formula:
C8H11N2NaO3
Molecular Weight:
206.18
AlogP:
0.16
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
2.0
Source:
MENATETRENONE
4
Small molecule
Approved
Unknown
Unknown
Carcinoma, Hepatocellular; Renal Insufficiency, Chronic; Thrombosis; Osteoporosis; Osteoporosis, Postmenopausal
Unknown
MENATETRENONE
×
Maximum Phase:
4
First Approval:
None
UNII:
27Y876D139
Molecule Type:
Small molecule
Molecular Formula:
C31H40O2
Molecular Weight:
444.66
AlogP:
8.92
PSA:
34.14
HBD:
0.0
HBA:
#RotB:
11.0
Source:
PHOLCODINE
4
Small molecule
Approved
Unknown
Unknown
Cough
Unknown
PHOLCODINE
×
Maximum Phase:
4
First Approval:
None
UNII:
LPP64AWZ7L
Molecule Type:
Small molecule
Molecular Formula:
C23H30N2O4
Molecular Weight:
398.5
AlogP:
1.2
PSA:
54.4
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MEPHOBARBITAL
4
Small molecule
Approved
Unknown
Unknown
Epilepsy
Unknown
MEPHOBARBITAL
×
Maximum Phase:
4
First Approval:
None
UNII:
5NC67NU76B
Molecule Type:
Small molecule
Molecular Formula:
C13H14N2O3
Molecular Weight:
246.27
AlogP:
1.04
PSA:
66.48
HBD:
1.0
HBA:
#RotB:
2.0
Source:
SELENOMETHIONINE SE-75
4
Small molecule
Approved
OTHER
INJECTION
Unknown
Unknown
SELENOMETHIONINE SE-75
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IOBENGUANE SULFATE I-123
4
Small molecule
Approved
OTHER
INTRAVENOUS
Unknown
Unknown
IOBENGUANE SULFATE I-123
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IGURATIMOD
4
Small molecule
Approved
Unknown
Unknown
Lupus Nephritis; Sjogren's Syndrome; Arthritis, Rheumatoid
Cyclooxygenase-2 inhibitor
IGURATIMOD
×
Maximum Phase:
4
First Approval:
None
UNII:
4IHY34Y2NV
Molecule Type:
Small molecule
Molecular Formula:
C17H14N2O6S
Molecular Weight:
374.37
AlogP:
2.53
PSA:
114.71
HBD:
2.0
HBA:
#RotB:
6.0
Source:
ANAGESTONE ACETATE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
ANAGESTONE ACETATE
×
Maximum Phase:
4
First Approval:
None
UNII:
GNT396G9QT
Molecule Type:
Small molecule
Molecular Formula:
C24H36O3
Molecular Weight:
372.55
AlogP:
5.48
PSA:
43.37
HBD:
0.0
HBA:
#RotB:
2.0
Source:
SODIUM PHOSPHATE P-32
4
Small molecule
Approved
OTHER
INJECTION; ORAL
Unknown
Unknown
SODIUM PHOSPHATE P-32
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMOPROXAN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
AMOPROXAN
×
Maximum Phase:
4
First Approval:
None
UNII:
27RL57FCYM
Molecule Type:
Small molecule
Molecular Formula:
C22H35NO7
Molecular Weight:
425.52
AlogP:
2.63
PSA:
75.69
HBD:
0.0
HBA:
#RotB:
12.0
Source:
FLUNARIZINE
4
Small molecule
Approved
Unknown
Unknown
Migraine Disorders; Vertigo
Unknown
FLUNARIZINE
×
Maximum Phase:
4
First Approval:
None
UNII:
R7PLA2DM0J
Molecule Type:
Small molecule
Molecular Formula:
C26H26F2N2
Molecular Weight:
404.5
AlogP:
5.39
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
6.0
Source:
RAMOSETRON
4
Small molecule
Approved
Unknown
Unknown
Nausea; Neoplasms; Postoperative Nausea and Vomiting; Stomach Neoplasms; Vomiting
Unknown
RAMOSETRON
×
Maximum Phase:
4
First Approval:
None
UNII:
7ZRO0SC54Y
Molecule Type:
Small molecule
Molecular Formula:
C17H17N3O
Molecular Weight:
279.34
AlogP:
2.89
PSA:
50.68
HBD:
1.0
HBA:
#RotB:
2.0
Source:
ERDOSTEINE
4
Small molecule
Approved
Unknown
Unknown
Bronchitis, Chronic; Pulmonary Disease, Chronic Obstructive
Anti-inflammatory, anti-oxidant
ERDOSTEINE
×
Maximum Phase:
4
First Approval:
None
UNII:
76J0853EKA
Molecule Type:
Small molecule
Molecular Formula:
C8H11NO4S2
Molecular Weight:
249.31
AlogP:
-0.05
PSA:
83.47
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PIPERIDOLATE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PIPERIDOLATE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
57UA660ILV
Molecule Type:
Small molecule
Molecular Formula:
C21H26ClNO2
Molecular Weight:
359.9
AlogP:
3.85
PSA:
29.54
HBD:
0.0
HBA:
#RotB:
5.0
Source:
PIRACETAM
4
Small molecule
Approved
Unknown
Unknown
Cocaine-Related Disorders; Anxiety; Dementia; Depressive Disorder; Movement Disorders; Postpoliomyelitis Syndrome; Schizophrenia; Attention Deficit Disorder with Hyperactivity
Unknown
PIRACETAM
×
Maximum Phase:
4
First Approval:
None
UNII:
ZH516LNZ10
Molecule Type:
Small molecule
Molecular Formula:
C6H10N2O2
Molecular Weight:
142.16
AlogP:
-0.91
PSA:
63.4
HBD:
1.0
HBA:
#RotB:
2.0
Source:
FENOTEROL
4
Small molecule
Approved
Unknown
Unknown
Heart Failure; Asthma; Pulmonary Disease, Chronic Obstructive; Lung Diseases, Obstructive
Beta-2 adrenergic receptor agonist
FENOTEROL
×
Maximum Phase:
4
First Approval:
None
UNII:
22M9P70OQ9
Molecule Type:
Small molecule
Molecular Formula:
C17H21NO4
Molecular Weight:
303.36
AlogP:
2.06
PSA:
92.95
HBD:
5.0
HBA:
#RotB:
6.0
Source:
BUTETHAL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
BUTETHAL
×
Maximum Phase:
4
First Approval:
None
UNII:
OHZ8QAW6YC
Molecule Type:
Small molecule
Molecular Formula:
C10H16N2O3
Molecular Weight:
212.25
AlogP:
0.94
PSA:
75.27
HBD:
2.0
HBA:
#RotB:
4.0
Source:
FERRIC CHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
FERRIC CHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
U38V3ZVV3V
Molecule Type:
Small molecule
Molecular Formula:
Cl3Fe
Molecular Weight:
162.2
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ZIMELDINE HYDROCHLORIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Serotonin (5-HT) receptor antagonist
ZIMELDINE HYDROCHLORIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
2T97D1P85R
Molecule Type:
Small molecule
Molecular Formula:
C16H21BrCl2N2O
Molecular Weight:
408.17
AlogP:
3.84
PSA:
16.13
HBD:
0.0
HBA:
#RotB:
4.0
Source:
PHENOXYETHANOL
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
PHENOXYETHANOL
×
Maximum Phase:
4
First Approval:
None
UNII:
HIE492ZZ3T
Molecule Type:
Small molecule
Molecular Formula:
C8H10O2
Molecular Weight:
138.17
AlogP:
1.06
PSA:
29.46
HBD:
1.0
HBA:
#RotB:
3.0
Source:
AMOBARBITAL
4
Small molecule
Approved
Unknown
Unknown
Osteoarthritis
Unknown
AMOBARBITAL
×
Maximum Phase:
4
First Approval:
None
UNII:
GWH6IJ239E
Molecule Type:
Small molecule
Molecular Formula:
C11H18N2O3
Molecular Weight:
226.28
AlogP:
1.39
PSA:
78.76
HBD:
2.0
HBA:
#RotB:
4.0
Source:
SODIUM BROMIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
SODIUM BROMIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
LC1V549NOM
Molecule Type:
Small molecule
Molecular Formula:
BrNa
Molecular Weight:
102.89
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ACEMETACIN
4
Small molecule
Approved
Unknown
Unknown
Rheumatic Diseases
Cyclooxygenase inhibitor
ACEMETACIN
×
Maximum Phase:
4
First Approval:
None
UNII:
5V141XK28X
Molecule Type:
Small molecule
Molecular Formula:
C21H18ClNO6
Molecular Weight:
415.83
AlogP:
3.47
PSA:
94.83
HBD:
1.0
HBA:
#RotB:
6.0
Source:
COUMARIN
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
COUMARIN
×
Maximum Phase:
4
First Approval:
None
UNII:
A4VZ22K1WT
Molecule Type:
Small molecule
Molecular Formula:
C9H6O2
Molecular Weight:
146.14
AlogP:
1.79
PSA:
30.21
HBD:
0.0
HBA:
#RotB:
0.0
Source:
DITHIAZANINE IODIDE
4
Small molecule
Approved
Unknown
Unknown
Unknown
Unknown
DITHIAZANINE IODIDE
×
Maximum Phase:
4
First Approval:
None
UNII:
8OEC3RA07X
Molecule Type:
Small molecule
Molecular Formula:
C23H23IN2S2
Molecular Weight:
518.49
AlogP:
6.25
PSA:
7.12
HBD:
0.0
HBA:
#RotB:
5.0
Source:
CYANOCOBALAMIN CO-60
4
Small molecule
Approved
OTHER
ORAL
Unknown
Unknown
CYANOCOBALAMIN CO-60
×
Maximum Phase:
4
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
163
164
165
166
167
168
169
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA